BMS-639623 is a potent and orally active CCR3 antagonist with an IC 50 of 0.3 nM. BMS-639623 picomolar inhibition potency against eosinophil chemotaxis (IC 50 =38 pM). BMS-639623 can be used for the research of asthma.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > CCR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。